Aug 31, 2009 by Brian Orelli, PhDDon't Let Dummy Pills Make You a Dummy InvestorThe sugar pill is getting stronger.
Aug 31, 2009 by Brian Orelli, PhDGood Luck, Genzyme -- You'll Need ItThe drugmaker faces an FDA advisory-panel showdown.
Aug 28, 2009 by Brian Orelli, PhDNow That's Healthy InnovationUnitedHealth lowers costs through an adherence-incentive program.
Aug 28, 2009 by Brian Orelli, PhDIs There Life After a 714% Return?It doesn't get any less risky for Immunomedics.
Aug 28, 2009 by Brian Orelli, PhDYour Doctor Is Killing You ... FinanciallyWhat the doctor does has a big effect on how much health care costs.
Aug 27, 2009 by Brian Orelli, PhDThe List You Have to Be OnGood for you if your company's products made the cut in China.
Aug 27, 2009 by Brian Orelli, PhDElan and J&J, Sitting in a Tree ...Johnson & Johnson dumps Alkermes for its new best bud.
Aug 27, 2009 by Brian Orelli, PhDHealth-Care Reform: If You Can't Beat 'Em, Join 'Em?America could learn something from one country across the pond.
Aug 26, 2009 by Brian Orelli, PhDAmgen Falls Back on the FutureUnfortunately, there's no rabbit in the hat.
Aug 26, 2009 by Brian Orelli, PhDThis One's Growing Through the RecessionMyriad Genetics is fairly resistant.
Aug 26, 2009 by Brian Orelli, PhDCould Health-Care Reform Fix Your Sick Portfolio?The government is making these stocks ill at ease.
Aug 25, 2009 by Brian Orelli, PhDThat's How You Want to Spend Investors' Money?A high-growth buyback? Really?
Aug 25, 2009 by Brian Orelli, PhDHow to Keep From Losing Your ShirtMore side effects for weight-loss drugs -- maybe.
Aug 25, 2009 by Brian Orelli, PhDMedtronic Takes the Road Less TraveledAnd it looks like the medical devices company is healthy again.
